Three isostructural solvates of finasteride and their solid-state characterization

European Journal of Pharmaceutical Sciences

Volumn 38, Issue 5, 2009, Pages 498-503

  Schultheiss, Nate ^a   Smit, Jared P ^a   Hanko, Jason A ^a  

^a Aptuit Inc   (United States)

Author keywords

Finasteride; Isostructural solvates; Pharmaceutical; X ray diffraction; X ray powder indexing

Indexed keywords

2 BUTANONE; ACETONE; FINASTERIDE; TOLUENE;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG STRUCTURE; PRIORITY JOURNAL; SOLID STATE; SOLVATE;

CHEMISTRY, PHARMACEUTICAL; FINASTERIDE; PHARMACEUTICAL SOLUTIONS; SOLUBILITY; SOLVENTS; STEREOISOMERISM; X-RAY DIFFRACTION;

EID: 70449524218     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2009.09.014     Document Type: Article

References (18)

1. Badu J.M., Kumar Y.R., Yvas K., Reddy G.O., Rajan S.T., and Reddy M.S.N. N-tert-butyl-3-oxo-4-aza-5β, 17β-androstane-17-carboxamide methanol solvate, a finasteride impurity. Acta Crystallogr. C55 (1999) IUC9900105
2. Byrn S.R., Pfeiffer R.R., and Stowell J.G. Solid-state Chemistry of Drugs (1999), SSCI, Inc. West Lafayette and references therein
3. Griesser U.J. The importance of solvates. In: Hilfiker R. (Ed). Polymorphism in the Pharmaceutical Industry (2006), Wiley-VCH 211-233
4. Guo Y., Byrn S.R., and Zografi G. Physical characteristics and chemical degradation of amorphous quinapril hydrochloride. J. Pharm. Sci. 89 (1999) 128-143
5. Laugier J., and Bochu B. Programme d'àffinement des paramèters de maille à partir d'un diagramme de poudre (2005). http://www.inpg.fr/LMGP http://www.inpg.fr/LMGP
6. McArdle P. ABSEN-a PC computer program for listing systematic absences and space-group determinations. J. Appl. Crystallogr. 29 (1996) 306
7. Meseguer, J.D., Codes, R.B., Ciriza, S.A., WO/1991/000865. A novel stable form of cephradine, process for its production and intermediates used therein.
8. Morris K. Structural aspects of hydrates and solvates. In: Brittian H.G. (Ed). Polymorphism in Pharmaceutical Solids (1999), Marcel Dekker, New York 125-179
9. Morzycki J.W., Wawer I., Gryszkiewicz A., Maj L., Siergiejczyk L., and Zaworska A. C-13-NMR study of 4-azasteroids in solution and solid state. Steroids 67 (2002) 621-626
10. Oszlányi G., and Süto A. Ab initio structure solution by charge flipping. Acta Crystallogr. A60 (2004) 134-141
11. Othman A., Evans J.S.O., Evans I.R., Harris R.K., and Hodgkinson P. Structural study of polymorphs and solvates of finasteride. J. Pharm. Sci. 96 (2007) 1380-1397
12. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 (1997) 307-326
13. Ressler C. Solid-state dehydrogenation of L-1 4-cyclohexadiene-1-alanine hydrate to l-phenylalanine. J. Org. Chem. 37 (1972) 2933-2936
14. Shefter E., and Higuchi T. Dissolution behavior of crystalline solvated and nonsolvated forms of some pharmaceuticals. J. Pharm. Sci. 52 (1965) 781-791
15. Spek A.L. Single-crystal structure validation with the program PLATON. J. Appl. Crystallogr. 36 (2003) 7-13
16. Stephenson G.A. Anisotropic lattice contraction in pharmaceuticals: the influence of cryo-crystallography on calculated powder diffraction patterns. J. Pharm. Sci. 95 (2006) 821-827
17. Wawrzycka I., Ste{ogonek}pniak K., Matyjaszczyk S., Kozioł A.E., Lis T., and Abboud K.A. Structural characterization of polymorphs and molecular complexes of finasteride. J. Mol. Struct. 474 (1999) 157-166
18. Wenslow R.M., Baum M.W., Ball R.G., McCauley J.A., and Varsolona R.J. A spectroscopic and crystallographic study of polymorphism in an aza-steroid. J. Pharm. Sci. 89 (2000) 1271-1285